Solutions for the Next Generation of Novel Therapies. AMPEL BioSolutions is dedicated to finding the right drug for the right patient at the right time. We are a multifaceted biomedical company utilizing both data and clinical science to facilitate drug target identification and validation. Together, our team has the tools and expertise - a global understanding of the biomedical field, basic/clinical research, medicine, and risk management - to creatively and efficiently bring specific and effective solutions to the most challenging research, discovery, and developmental problems.
Looking for a particular AMPEL BioSolutions employee's phone or email?
The AMPEL BioSolutions annual revenue was $14 million in 2026.
Amrie Grammer is the President of AMPEL BioSolutions.
9 people are employed at AMPEL BioSolutions.
AMPEL BioSolutions is based in Charlottesville, Virginia.
The NAICS codes for AMPEL BioSolutions are [54, 54171, 5417, 541, 541714].
The SIC codes for AMPEL BioSolutions are [87, 873].